Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Veroderm Medical Technologies, branded on its website as Veroderm Medical Biotechnologies, is a healthcare and medical-technology company focused on aesthetic devices, skin and wound biotechnology, diagnostic support, and related biomedical systems. The company says it was established in 2004 and markets a portfolio that includes medical aesthetics equipment, ultrasound and Doppler imaging systems, regenerative skin and wound-care solutions, and diagnostic investigative biomedicine services. Its offerings appear to be organized into branded business lines including VeroDERMATECH, VeroSONICS, VeroSKINTECH, VeroBIOTECH, and VeroMEDICS. Veroderm emphasizes bio-regenerative and nano-biotechnology approaches for skin repair, chronic wound management, and practitioner-facing treatment protocols. Based on the available information, it is better characterized as a commercial medical device and healthcare solutions company than as a traditional therapeutic biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Veroderm Medical Technologies.